Chengdu Easton Biopharmaceuticals Co., Ltd.
Status: Publicly traded
Direct answer
Chengdu Easton Biopharmaceuticals Co., Ltd. is publicly traded on SHH under the ticker 688513.SS.
Chengdu Easton Biopharmaceuticals Co., Ltd. is a pharmaceutical enterprise dedicated to the full spectrum of drug development, encompassing research, development, production, and market distribution of medicinal products. The company offers finished medications tailored for various medical disciplines, including pain management (anesthetics/analgesics), cardiovascular health, oncology, and pediatrics. Beyond...
Can you invest in Chengdu Easton Biopharmaceuticals Co., Ltd.?
Yes. Chengdu Easton Biopharmaceuticals Co., Ltd. trades publicly on SHH as 688513.SS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Chengdu Easton Biopharmaceuticals Co., Ltd.
Detailed equity research is provided by MarketSnap.